By Katherine Hamilton
Bayer filed for the Supreme Court to review a lower court's decision on a case alleging the company's Roundup product caused cancer.
Bayer said Friday it had filed a petition for a writ of certiorari with the Supreme Court, arguing that a split among federal circuit courts in the Roundup litigation warrants review and resolution by the top court.
In 2023, a Missouri Circuit Court returned a verdict in favor of John Durnell, who alleged the weed control product Roundup caused non-Hodgkin's lymphoma. Bayer bought the agrochemical company Monsanto, which makes Roundup, in 2018.
The Missouri court's verdict rests on the claim that state law requires companies to warn if their products are carcinogenic, Bayer said.
Different courts have reached different conclusions, which is why Bayer is arguing the Supreme Court needs to rule on the issue.
Tens of thousands of Roundup cases are pending in state and federal courts. The ongoing litigation threatens Monsanto's ability to supply glyphosate-based products, Bayer said.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
April 04, 2025 15:14 ET (19:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。